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Abstract. Methods of predicting relapsing hemorrhage. Trofimov M.V., Kryshen V.P., Gaponov I.V. In this 
article the authors presented their own original methods for predicting ulcerous gastroduodenal bleeding defended by 
Patent of Ukraine. The implementation of these procedures led to substantial lowing of recurrent hamorrhage rate – 
more than twice. All methods have pathogenetic foundation and are based on ulcerogenesis mechanisms revealed 
during the longlasting complex clinical and experimental research. In such a way surgeons obtain some possibilities of 
early diagnostics of bleeding relapses and adequate treatment and effective hemorrhage prevention accordingly.  
 
Реферат. Методи прогнозування рецидивної кровотечі. Трофімов М.В., Кришень В.П., Гапонов І.В. У цій 
статті автори презентували власні оригінальні методи прогнозування рецидиву виразкової гастро-
дуоденальної кровотечі, захищені патентом України. Реалізація цих методів сприяла суттєвому зменшенню 
кількості рецидивних кровтеч - більше ніж у два рази. Всі методи мають патогенетичну основу і базуються 
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на механізмах патогенезу, виявлених під час тривалого комплексного клініко-експериментального дослідження. 
Таким чином, хірурги отрумують можливість ранньої діагностики рецидивів кровотечі і відповідно 
адекватного лікування та ефективної профілактики крововтрати. 
 
Complex observation of 143 patients with 
bleeding gastroduodenal ulcer was conducted. Pa-
thophysiologically grounded principles of predicting  
relapsing hemorrhage have been developed by us 
based on data of pathomorphological, immu-
nehistochemical and microbiological research of the 
ulcer substrate in case of active bleeding, at stopped 
bleeding with signs of unstable local endoscopic 
hemostasis and high risk for manifestation of re-
lapsing hemorrhage in the clinic. 
MATERIALS AND METHODS  
According to our data, the main chain of patho-
genesis of appearing relapsing hemorrhage is the 
increase in blood filling of the periulcerous area and 
especially blood deposition in dilated vessels of sub-
mucosal vascular plexus directly under the ulcer 
defect. For predicting relapsing bleeding, as a basis 
we used research of indices, which are directly 
connected with the increase in blood filling of the 
periulcerous area. Local increase in activity of i-
NOS due to leucocyte infiltration of the mentioned 
area causes the increase of blood filling in the 
periulcerous area. Finding out the level of activity of 
i-NOS in periulcerous area on the third day of 
staying in the hospital in cases of unstable local 
endoscopic hemostasis will enable doctors to apply 
some measures for preventing this severe com-
plication.  
The suggested method (Patent of Ukraine for the 
useful model #59395 “Way of defining the risk of 
relapse of gastroduodenal hemorrhage of ulcer ge-
nesis” is carried out in the following way.The patient 
with the arrested bleeding by conservative and 
endoscopic means, while carrying out endoscopic 
monitoring has local hemostasis defined by Forrest 
and targeted biopsy of mucous of stomach and 
duodenum is carried out near the area of the defect 
(1-1.5 mm). After that, immunohistochemical re-
search is carried out to define the activity of 
inducible NO-synthase using Scarpelli method. High 
risk of hemorrhage relapse is determined by the 
presence of more than 5 cells colored in blue within 
the field of the view, low risk – from 3 till 5 cells, 
absence – less than 3 cells. 
Upon carrying out clinical researches we re-
vealed the correlational connection between the 
character of microbe semination of the periulcerous 
area and local level of i-NOS activity and stage of 
the local endoscopic hemostasis. In case of impos-
sibility to carry out specific immunohistochemical 
research, we developed a method of indirect esti-
mation of risk of relapsing hemorrhage (Patent of 
Ukraine for the useful model #59731 “The method 
of endoscopic diagnostics of relapsing stomach-
intestinal hemorrhage.” 
The suggested method includes selection of 
mucous biopsy materials around the hemorrhage 
area (around 2 mm) and microbiological research. 
The character of bacterial semination, its qualitative 
and quantitative analyses enable researchers to 
conclude the possible threat of relapsing hemorrhage 
and effectiveness of the carried out endoscopic 
hemostasis and conservative therapy. High risk for 
relapsing hemorrhage is set when the level of micro-
organisms of type Klebsiella pneumoniаe and Strep-
tococcus -haemoliticus are present in biopsy ma-
terials of mucous of stomach and esophagus in the 
amount of over 106–107, and low level of relapsing 
hemorrhage – if semination of microorganisms of 
type Klebsiella pneumoniаe and Streptococcus -
haemoliticus in samples is 104–105. The absence of 
relapsing hemorrhage is defined if concentration of 
microorganisms of type Klebsiella pneumoniаe and 
Streptococcus -haemoliticus in those samples is 
102–103. 
The mentioned method is carried out in the fol-
lowing way. The patient with signs of unstable endo-
scopic hemostasis or with the arrested hemorrhage 
by endoscopic ways, esophagogastroduodenal study 
is carried out for endoscopic monitoring. After that 
the condition of local endoscopic hemostasis by For-
rest is estimated and targeted biopsy of mucous of 
stomach or duodenum is taken at the distance of 1-
1.5 mm from the side of the ulcerous defect. Se-
lection of biopsy material is carried out using biopsy 
pincers FB-IF. While taking samples of biopsy of 
mucous of stomach and duodenum for microbio-
logical research it is essential to exclude the pos-
sibility of contaminating the studied material by out-
side micro flora.  
The given above ways of predicting relapsing he-
morrhage are quite invasive for patients and require 
application of special tools and laboratory equip-
ment. Due to that, it is essential to develop such a 
method of predicting relapsing hemorrhage which 
would be mini-invasive, available, quick and simple 
with application of technique, acceptable price and 
mainly precision of diagnostics which could be 
considered as a screening method.  
Therefore based on carried out experiments and 
clinical researches we developed our own way of 
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defining the risk of gastrointestinal hemorrhage 
relapse of ulcerous genesis (Patent of Ukraine on the 
helpful model # 59730 “Way of defining stomach-
intestinal relapsing hemorrhage”). The essence of 
the suggested approach is in sampling venous blood 
from the patient on arrival at the hospital and 
determination of stable metabolites NO in serum. On 
the third day of treatment the sample of venous 
blood is taken repeatedly, with further definition of 
stable metabolites of NO in serum. The increase in 
level of stable metabolites NO is caused by the 
increase of i-NOS activity in periulcerous area, 
which can be explained by the expressed leukocyte 
infiltration with preference of the lymph chain. At 
increase in NO production, manifested vasodila-
tation, blockage of vasoconstriction, depression of 
clot formation are observed. These changes cause 
the blood filling of the periulcerous area that could 
lead to development of bleeding and create some 
conditions for recurrent hemorrhage.  
The suggested method is carried out in the fol-
lowing way. During the esophagogastroduodenos-
copy the presence, localization and character of 
ulcer defect of mucosa are defined along with the 
local hemostasis by Forrest. At that the sampling of 
5 ml of blood from the peripheral vein is carried out. 
The blood sample is centrifuged for taking serum.  
On the third day of stay the patient underwent 
repeated definition of stable metabolites of NO in 
blood serum according to the methodology men-
tioned above. The high risk of relapsing hemorrhage 
is defined using the following criteria: if the level of 
stable metabolites NO increases 70% and more 
compared with the previous – high level; low level 
of relapsing hemorrhage – if the level of stable me-
tabolites NO increases not more than 35-70% com-
pared to the previous one; absence of relapsing 
hemorrhage – if level of stable metabolites NO in-
creases less than 35% compared to the previous level. 
CONCLUSION 
The implementation of the presented methods of 
defining the risk for gastrointestinal relapsing he-
morrhage of ulcerous genesis can be used in every 
hospital, besides it does not require expensive and 
sophisticated equipment and trained personnel. High 
precision of diagnostics, rapid results (within 2-3 
hours) and low price are significant in the screening 
procedure. The application of elaborateded tech-
niques has been allowed to decrease the rate of 
recurrent bleeding from 10,5% to 4,2%. 
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